Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With Connective Tissue Disease-related Interstitial Lung Disease

by | Mar 27, 2026 | Clinical Trials | 0 comments

​ Conditions: CTD-ILD

Interventions: Drug: Telitacicept; Drug: Placebo

Sponsors: RemeGen Co., Ltd.

Not yet recruiting Conditions: CTD-ILD
Interventions: Drug: Telitacicept; Drug: Placebo
Sponsors: RemeGen Co., Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *